SANIVEX HEALTHCARE PVT. LTD.

Mycophenolate sodium (Myfortic® of Novartis) is an immunosuppressant drug used to prevent rejection in organ transplantation. It inhibits an enzyme needed for the growth of T cells and B cells. Mycophenolate sodium is indicated for the prevention of renal transplant rejection in adults. Mycophenolate sodium has also been used for the prevention of rejection in liver, heart, and/or lung transplants in children older than two years.An immunosuppressant that has drastically decreased the incidence of acute rejection in solid transplant recipients, Mycophenolate sodium is increasingly utilized as a steroid sparing treatment in immune-mediated disorders including immunoglobulin-A nephropathy, small vessel vasculitides, and psoriasis.